Cargando…

P474 The value of PCR-based azole resistance detection in invasive aspergillosis: A prospective multicenter study

POSTER SESSION 1, SEPTEMBER 21, 2022, 12:30 PM - 1:30 PM:   OBJECTIVES: Prompt detection of azole-resistant Aspergillus fumigatus will result in the timely start of active treatment and may improve the survival of invasive aspergillosis (IA). The use of a multiplex polymerase chain reaction (PCR) ta...

Descripción completa

Detalles Bibliográficos
Autores principales: Huygens, Sammy, Dunbar, Albert, Buijl, Jochem, Maertens, Johan, Verweij, Paul, Klaassen, Corne, Lagrou, Katrien, Van Dijk, Karin, Mercier, Toine, Schauwvlieghe, Alexander, Rijnders, Bart
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9516266/
http://dx.doi.org/10.1093/mmy/myac072.P474
_version_ 1784798670235893760
author Huygens, Sammy
Dunbar, Albert
Buijl, Jochem
Maertens, Johan
Verweij, Paul
Klaassen, Corne
Lagrou, Katrien
Van Dijk, Karin
Mercier, Toine
Schauwvlieghe, Alexander
Rijnders, Bart
author_facet Huygens, Sammy
Dunbar, Albert
Buijl, Jochem
Maertens, Johan
Verweij, Paul
Klaassen, Corne
Lagrou, Katrien
Van Dijk, Karin
Mercier, Toine
Schauwvlieghe, Alexander
Rijnders, Bart
author_sort Huygens, Sammy
collection PubMed
description POSTER SESSION 1, SEPTEMBER 21, 2022, 12:30 PM - 1:30 PM:   OBJECTIVES: Prompt detection of azole-resistant Aspergillus fumigatus will result in the timely start of active treatment and may improve the survival of invasive aspergillosis (IA). The use of a multiplex polymerase chain reaction (PCR) targeting Aspergillus species and fumigatus DNA as well as the two most prevalent azole resistance- associated mutations (RAMs) in the cyp51A gen (TR34/L98H and TR46/Y121F/T289A) could shorten the time to detect azole-resistant IA. METHODS: In a prospective study in 12 Dutch and Belgian centers, we evaluated the clinical value of the multiplex AsperGenius®PCR in hematology patients with a pulmonary infiltrate undergoing bronchoalveolar lavage (BALf) sampling. The primary endpoint was antifungal treatment failure in the 6 weeks after antifungal treatment initiation in the patients in which azole-resistant IA was detected. Treatment failure was defined as death or a switch to an antifungal agent from another class after at least 5 days of first-line therapy. Patients with a mixed azole-susceptible/resistant infection were excluded from this analysis to ascertain that the infection was indeed caused by the resistant strain. RESULTS: Of 323 patients enrolled, sufficient BALf for PCR testing remained in 299. Probable fungal disease was diagnosed in 95 (34%), Aspergillus cultured in 24 (8%), Aspergillus DNA detected in 118 (39%), and A. fumigatus DNA in 88 (29%) patients. The resistance PCR was conclusive in 54/88 (61%) and RAMs were detected in 8 (15%), Table 1. All 8 had probable IA but 2 had a mixed infection and were excluded. In the 6 remaining patients, treatment failure was observed in one. Compared with the GM negative patients and despite antifungal therapy, a positive GM test was associated with a 13% higher 6-week overall mortality (P = .01), Table 2. Surprisingly, the 6-week mortality in the 65 patients who had a positive Aspergillus PCR but a negative GM and culture was not increased compared to those with a negative PCR (PCR + 14% vs. PCR- 16% mortality, P = .68). CONCLUSIONS: In patients with an underlying hematological disease and a pulmonary infiltrate, the detection of Aspergillus DNA by PCR on BALf was not associated with increased mortality. The exact place of the Aspergillus PCR in the EORTC-MSGERC invasive fungal infection criteria is therefore uncertain. In 15% of the patients in whom A. fumigatus DNA was present, azole RAMs were detected by PCR. In only 1/6 probable cases of IA with RAMs detected, antifungal treatment failure was observed. Basing the choice of antifungal therapy on the result of a cyp51a resistance PCR may help to reduce the impact of azole resistance on mortality.
format Online
Article
Text
id pubmed-9516266
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-95162662022-09-29 P474 The value of PCR-based azole resistance detection in invasive aspergillosis: A prospective multicenter study Huygens, Sammy Dunbar, Albert Buijl, Jochem Maertens, Johan Verweij, Paul Klaassen, Corne Lagrou, Katrien Van Dijk, Karin Mercier, Toine Schauwvlieghe, Alexander Rijnders, Bart Med Mycol Oral Presentations POSTER SESSION 1, SEPTEMBER 21, 2022, 12:30 PM - 1:30 PM:   OBJECTIVES: Prompt detection of azole-resistant Aspergillus fumigatus will result in the timely start of active treatment and may improve the survival of invasive aspergillosis (IA). The use of a multiplex polymerase chain reaction (PCR) targeting Aspergillus species and fumigatus DNA as well as the two most prevalent azole resistance- associated mutations (RAMs) in the cyp51A gen (TR34/L98H and TR46/Y121F/T289A) could shorten the time to detect azole-resistant IA. METHODS: In a prospective study in 12 Dutch and Belgian centers, we evaluated the clinical value of the multiplex AsperGenius®PCR in hematology patients with a pulmonary infiltrate undergoing bronchoalveolar lavage (BALf) sampling. The primary endpoint was antifungal treatment failure in the 6 weeks after antifungal treatment initiation in the patients in which azole-resistant IA was detected. Treatment failure was defined as death or a switch to an antifungal agent from another class after at least 5 days of first-line therapy. Patients with a mixed azole-susceptible/resistant infection were excluded from this analysis to ascertain that the infection was indeed caused by the resistant strain. RESULTS: Of 323 patients enrolled, sufficient BALf for PCR testing remained in 299. Probable fungal disease was diagnosed in 95 (34%), Aspergillus cultured in 24 (8%), Aspergillus DNA detected in 118 (39%), and A. fumigatus DNA in 88 (29%) patients. The resistance PCR was conclusive in 54/88 (61%) and RAMs were detected in 8 (15%), Table 1. All 8 had probable IA but 2 had a mixed infection and were excluded. In the 6 remaining patients, treatment failure was observed in one. Compared with the GM negative patients and despite antifungal therapy, a positive GM test was associated with a 13% higher 6-week overall mortality (P = .01), Table 2. Surprisingly, the 6-week mortality in the 65 patients who had a positive Aspergillus PCR but a negative GM and culture was not increased compared to those with a negative PCR (PCR + 14% vs. PCR- 16% mortality, P = .68). CONCLUSIONS: In patients with an underlying hematological disease and a pulmonary infiltrate, the detection of Aspergillus DNA by PCR on BALf was not associated with increased mortality. The exact place of the Aspergillus PCR in the EORTC-MSGERC invasive fungal infection criteria is therefore uncertain. In 15% of the patients in whom A. fumigatus DNA was present, azole RAMs were detected by PCR. In only 1/6 probable cases of IA with RAMs detected, antifungal treatment failure was observed. Basing the choice of antifungal therapy on the result of a cyp51a resistance PCR may help to reduce the impact of azole resistance on mortality. Oxford University Press 2022-09-20 /pmc/articles/PMC9516266/ http://dx.doi.org/10.1093/mmy/myac072.P474 Text en © The Author(s) 2022. Published by Oxford University Press on behalf of The International Society for Human and Animal Mycology. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs licence (https://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited. For commercial re-use, please contact journals.permissions@oup.com
spellingShingle Oral Presentations
Huygens, Sammy
Dunbar, Albert
Buijl, Jochem
Maertens, Johan
Verweij, Paul
Klaassen, Corne
Lagrou, Katrien
Van Dijk, Karin
Mercier, Toine
Schauwvlieghe, Alexander
Rijnders, Bart
P474 The value of PCR-based azole resistance detection in invasive aspergillosis: A prospective multicenter study
title P474 The value of PCR-based azole resistance detection in invasive aspergillosis: A prospective multicenter study
title_full P474 The value of PCR-based azole resistance detection in invasive aspergillosis: A prospective multicenter study
title_fullStr P474 The value of PCR-based azole resistance detection in invasive aspergillosis: A prospective multicenter study
title_full_unstemmed P474 The value of PCR-based azole resistance detection in invasive aspergillosis: A prospective multicenter study
title_short P474 The value of PCR-based azole resistance detection in invasive aspergillosis: A prospective multicenter study
title_sort p474 the value of pcr-based azole resistance detection in invasive aspergillosis: a prospective multicenter study
topic Oral Presentations
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9516266/
http://dx.doi.org/10.1093/mmy/myac072.P474
work_keys_str_mv AT huygenssammy p474thevalueofpcrbasedazoleresistancedetectionininvasiveaspergillosisaprospectivemulticenterstudy
AT dunbaralbert p474thevalueofpcrbasedazoleresistancedetectionininvasiveaspergillosisaprospectivemulticenterstudy
AT buijljochem p474thevalueofpcrbasedazoleresistancedetectionininvasiveaspergillosisaprospectivemulticenterstudy
AT maertensjohan p474thevalueofpcrbasedazoleresistancedetectionininvasiveaspergillosisaprospectivemulticenterstudy
AT verweijpaul p474thevalueofpcrbasedazoleresistancedetectionininvasiveaspergillosisaprospectivemulticenterstudy
AT klaassencorne p474thevalueofpcrbasedazoleresistancedetectionininvasiveaspergillosisaprospectivemulticenterstudy
AT lagroukatrien p474thevalueofpcrbasedazoleresistancedetectionininvasiveaspergillosisaprospectivemulticenterstudy
AT vandijkkarin p474thevalueofpcrbasedazoleresistancedetectionininvasiveaspergillosisaprospectivemulticenterstudy
AT merciertoine p474thevalueofpcrbasedazoleresistancedetectionininvasiveaspergillosisaprospectivemulticenterstudy
AT schauwvlieghealexander p474thevalueofpcrbasedazoleresistancedetectionininvasiveaspergillosisaprospectivemulticenterstudy
AT rijndersbart p474thevalueofpcrbasedazoleresistancedetectionininvasiveaspergillosisaprospectivemulticenterstudy